If this cluster has one combination to treat as genuinely dangerous rather than merely uncertain, it is lithium. An analysis of online experience reports describing classic psychedelics taken alongside mood stabilizers found that a large fraction of the lithium accounts involved seizures, while none of the comparison lamotrigine accounts did. That is a clear, internally consistent signal, and a seizure is a serious enough outcome that the combination is singled out for the highest caution in the literature. What the evidence is, though, is case reports — not a controlled study. It establishes that serious harm has occurred when the two are combined; it does not tell us how often, under what conditions, by what mechanism, or whether the risk extends to microdoses, which were not what these reports described. The honest reading: documented danger, undocumented rate. This is not medical advice, and lithium is never something to stop or adjust on your own.
This is an evidence review, not medication guidance. Whether an interaction matters depends on dose, diagnosis, medication history, timing, and individual vulnerability. Nothing here should be used to start, stop, combine, or adjust a prescribed medication — those decisions belong with the clinician who prescribed it.
A different kind of entry in this cluster
Most of this cluster trades in mechanism and survey data, where the recurring caution is that plausibility is not proof. Lithium is the exception that proves the cluster’s seriousness: here there is documented harm, not just a worrying mechanism. The central source is a 2021 analysis that gathered first- and second-person accounts, posted across three websites, of people who had taken a classic psychedelic — LSD, psilocybin, or DMT — together with a mood stabilizer. Among the lithium accounts, a striking proportion described seizures, with additional accounts describing severely adverse experiences; among the accounts involving lamotrigine, a different mood stabilizer, none described seizures. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794
That contrast is what gives the finding its weight. It is one thing to note that some people who combined lithium and a psychedelic had seizures; it is more telling that a comparison drug used for overlapping conditions did not show the same pattern in the same dataset. The signal is specific to lithium, not a vague worry about combining psychedelics with any psychiatric medication.
What case reports can and cannot establish
It is essential to be precise about the kind of evidence this is, because precision here protects people in both directions. Case reports and online experience accounts are a real and valuable source of safety signals — often the first place a dangerous interaction surfaces, long before any trial would study it. They are strong at answering “has serious harm occurred?” The lithium data answer that with a clear yes. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794
What case reports cannot do is establish a rate. They are collected from people motivated to report, with no denominator — we do not know how many people combined lithium and a psychedelic without incident and never posted about it. So the data cannot tell us whether seizures follow this combination in most cases or a minority, what blood levels or doses matter, or the biological mechanism, which remains incompletely characterized. [2] Systematic review Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review doi:10.1007/s00213-022-06083-y The reasoning behind this gap between “harm has occurred” and “here is the probability of harm” is the same logic laid out in how to read microdosing claims and why microdosing is difficult to study.
The correct conclusion is not to discount the signal because it comes from case reports — that would be exactly the wrong lesson when the outcome is seizures. It is to hold two facts together: the harm is real and documented, and the rate is unknown.
| Question | Answer from the evidence |
|---|---|
| Has serious harm (seizures) occurred? | Yes — documented in a substantial share of lithium accounts |
| Did a comparison mood stabilizer show it? | No — lamotrigine accounts did not show the seizure pattern |
| How often does it happen? | Unknown — case reports have no denominator |
| What is the mechanism? | Not fully characterized |
| Does it apply at microdoses? | Untested — reports involved full/recreational doses |
| Overall posture | Highest caution: documented danger, unquantified rate |
Why microdose status does not soften the verdict
A natural question is whether a sub-perceptual microdose escapes this risk. The honest answer is that nobody knows, and that uncertainty argues for more caution, not less. The seizure reports involved full or recreational doses, so there is no microdose-specific evidence either way. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 When the mechanism is not understood, you cannot assume a lower dose stays below some safe threshold, because there is no measured threshold to point to. Combine an unknown dose-response with an outcome as serious as a seizure, and the absence of microdose data becomes a reason to avoid the combination, not a loophole. [4] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
- Documented danger, not theory
- Unlike most of this cluster, the lithium concern rests on reports of actual seizures, not solely on a worrying mechanism. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794
- The lamotrigine contrast
- A comparison mood stabilizer did not show the seizure pattern, making the signal specific to lithium rather than to all mood stabilizers. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794
- Harm occurred ≠ known rate
- Case reports establish that serious harm has happened but cannot quantify how likely it is, because they have no denominator. [2] Systematic review Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review doi:10.1007/s00213-022-06083-y
- Uncertainty favours caution
- With an unknown mechanism and a seizure as the outcome, the lack of microdose data is a reason to avoid the combination, not to assume safety. [4] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
Frequently asked questions
Is it safe to microdose while taking lithium?
Lithium combined with a classic psychedelic is the one interaction in this cluster the literature flags as a documented danger rather than a theoretical one. An analysis of online experience reports found that a large share of accounts describing lithium taken with a psychedelic involved seizures, while a comparison mood stabilizer produced none. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794 The mechanism is not fully understood and the data are case reports rather than controlled studies, so the precise risk at microdose levels is unknown — but seizures are serious enough that this combination is consistently singled out for the highest caution. This is not medical advice. If you are prescribed lithium, this is a question for your prescribing psychiatrist, and you should never stop lithium on your own.
How strong is the evidence that lithium plus psilocybin causes seizures?
It is strong for a case-report signal and weak by the standard of controlled trials — and both are true at once. The key analysis examined dozens of online accounts of psychedelics taken with mood stabilizers and found seizures in a striking proportion of the lithium accounts and in none of the lamotrigine accounts, a clear and internally consistent contrast. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794 What case reports cannot establish is how often this happens across everyone who combines the two, what doses or conditions matter, or the exact mechanism. [2] Systematic review Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review doi:10.1007/s00213-022-06083-y So the evidence proves serious harm has occurred; it does not quantify the risk.
Does the seizure risk apply at microdose levels?
This is not known, and the uncertainty cuts toward caution rather than away from it. The case reports involved recreational and full doses, not documented microdoses, so there is no direct evidence about sub-perceptual amounts. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 With a mechanism that is not understood and an outcome as serious as a seizure, the absence of microdose-specific data is a reason to treat the combination as high-risk, not a reason to assume low doses are exempt. [4] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
Why is lithium singled out when other mood stabilizers aren't?
Because the data themselves drew that line. In the same analysis, accounts involving lamotrigine — another common mood stabilizer — did not show the seizure pattern that lithium accounts did. [1] Observational Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports doi:10.1055/a-1524-2794 That contrast is part of why the lithium signal is taken seriously: it is not a blanket worry about all psychiatric medication but a specific association that stood out against a comparison drug. It does not mean other combinations are safe, only that the seizure signal was specific to lithium in the available reports.
Should I stop or change my medication before microdosing?
No. Stopping, switching, or adjusting a prescribed medication carries its own serious risks — withdrawal, relapse, mood destabilization, or symptom rebound — independent of anything to do with psilocybin. Those decisions belong with the prescribing clinician who knows your history. This library describes what the research does and does not show; it is not a basis for changing treatment, and nothing here should be read as a reason to alter a prescribed medication on your own.